News

Displaying 201 - 220 of 734

open door

EMCDDA Best practice portal update

This content was published in the Best pratice portal update briefing on 18.03.2019 Treatment for amphetamine-type stimulants use disorders The use of amphetamines, methamphetamines and other amphetamine-type stimulants (like MDMA) is widespread...

Water drop

Latest wastewater data reveal drug-taking habits in over 70 European cities and an increase in the detection of stimulants

The latest findings from the largest European project in the emerging science of wastewater analysis are presented today by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA). The...

Working arrangement

EU drugs agency and the Republic of Albania strengthen their cooperation

The EU drugs agency (EMCDDA) and Albania will cooperate more actively on monitoring the drug phenomenon in future, thanks to a Working Arrangement being concluded today in Vienna (1). The agreement is...

EMCDDA building

CICAD–OAS Executive Secretary visits EMCDDA to discuss cooperation and perspectives for work programme 2019–23

Ambassador Adam Namm, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD) of the Organization of American States (OAS) visited the EMCDDA today to discuss with the agency’s Director Alexis Goosdeel...

International Women’s Day 2019 — Why gender matters in drug addiction

Around 37 million women in Europe have used an illicit drug at least once in their lifetime. Some 100 000 enter drug treatment every year and nearly 2 000 die from drug...

ECDC Executive Director Dr Andrea Ammon visits EMCDDA

Today, EMCDDA Director Alexis Goosdeel welcomes to the agency Dr Andrea Ammon, Executive Director of the Stockholm-based European Centre for Disease Prevention and Control (ECDC). The EMCDDA and ECDC have recently signed...

Xchange — 16 new programmes added to online registry of evidence-based prevention programmes

The EMCDDA has added 16 new programmes to Xchange, its online registry of evidence-based prevention programmes. Launched in October 2017, and now ending its pilot phase, the registry showcases interventions that European...

Network concept

EMCDDA intensifies its cooperation with the European Neighbourhood Policy countries

This year, the EMCDDA has launched a three-year project — EU4Monitoring Drugs (EU4MD) — which will intensify its cooperation with the countries of the European Neighbourhood Policy (ENP)(1)(2). The EU-funded project, running...

EMCDDA signs two new working arrangements with ECHA and EFSA

Two new working arrangements will be signed in Brussels today between the EMCDDA and the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA). The EMCDDA will now be cooperating...

Gold medal for the EMCDDA for the ‘extraordinary relevance’ of its work

The EMCDDA has been awarded a Gold Medal of the Order of Merit of the Spanish national plan on drugs (Delegación del Gobierno para el Plan Nacional sobre Drogas/DGPNSD) in recognition of...

Cannabis control and the right to privacy

In 2018 the highest courts in countries across three continents have asserted that state intervention in the private life of their citizens who wish to (grow and) use cannabis is not always...

Colorado publishes latest statistics on impact of cannabis legalisation

This news item was published in the EMCDDA’s Cannabis drug policy news on 17.12.2018 In the US state of Colorado, use and sale of cannabis for recreational purposes has been legal since...

Registration now open for the eighth European drugs summer school

The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces once again next summer to hold the eighth European drugs summer school (EDSS) on ‘Illicit drugs...

photo of the EMCDDA premises

Board re-elects French member Laura d’Arrigo as Chair and Austrian member Franz Pietsch as Vice-Chair

The EMCDDA Management Board, meeting in Lisbon this week, held elections today for the positions of Chair and Vice-Chair of the Board. Laura d’Arrigo (France), Diplomatic advisor at the French Interministerial Mission...

lines of cocaine on a mirror alongside a razor blade

Innovative EMCDDA monitoring method sheds light on changes in Europe’s cocaine market

The latest changes in Europe’s cocaine market are explored in a new report published today by the EU drugs agency (EMCDDA). The report follows an analysis in the European Drug Report 2018...

EMCDDA takes stock of EU-ANSA activities in 2018

This month, the EMCDDA approaches the end of its presidency of the EU Agencies’ Network on Scientific Advice (EU-ANSA) and looks back on a productive year (1). EU-ANSA is one of the...

Signature of working arrangements with five EU agencies

Europe’s ability to rapidly respond to public health and social threats caused by new psychoactive substances (NPS/‘new drugs’) has been significantly strengthened thanks to new legislation applying from 23 November (1). The...

EU drugs agency publishes its first report on the medical use of cannabis

What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue...

Reitox academy: professionalising the prevention workforce through standardised training

Over 50 representatives of the Reitox national focal points (NFPs) and decision-makers from more than 20 countries will gather in Prague this week for a Reitox academy on the theme of prevention...

microphone

Expert meeting to examine implementation of evidence-based interventions on drugs

Experts in the implementation of evidence-based interventions from Europe and North America are gathering at the EMCDDA this week for the agency’s first technical meeting on ‘Pathways to implementation’. Implementing responses to...